Reata Pharmaceuticals Inc
NASDAQ:RETA
Reata Pharmaceuticals Inc
Net Issuance of Debt
Reata Pharmaceuticals Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Reata Pharmaceuticals Inc
NASDAQ:RETA
|
Net Issuance of Debt
$72.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Debt
-$11.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Debt
$17.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Debt
$33.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
67%
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Debt
$3.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Debt
$7.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Reata Pharmaceuticals Inc's Net Issuance of Debt?
Net Issuance of Debt
72.6m
USD
Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Net Issuance of Debt amounts to 72.6m USD.
What is Reata Pharmaceuticals Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
4%